drugset / Trial / NCT05362188

Topical Nicotinamide in Treatment of DLE

NCT05362188

Phase 0 Completed 60 enrolled Al-Azhar University
RandomizedParallel-groupTriple-blindTreatment

Summary

Cutaneous lupus erythematosus (CLE) is lupus affecting the skin. In this autoimmune disease, the body's immune system attacks healthy skin. There are 3 main types: Acute cutaneous lupus, Subacute cutaneous lupus, and Chronic cutaneous lupus ("discoid lupus"). Lupus most often appears between the ages of 20 and 50 years; it affects women more than men, and it may happen more in patients with a family history of lupus or other autoimmune diseases.

Timeline

Start
2022-03-01
Primary completion
2022-09-01
Completion
2022-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotinamide Other / unclassified 2 % Topical
Subject Nicotinamide Other / unclassified 4 % Topical